4D Molecular Therapeutics, Inc. FDMT

Updated: 9 Aug 2026

NASDAQ | Biotech | Biotechnology and gene therapy

No signal published yet

We already track 4D Molecular Therapeutics and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow 4D Molecular Therapeutics free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Biotechnology and gene therapy
We're already tracking 4D Molecular Therapeutics, Inc. — here are the latest events we've registered

Recent News

  • On July 18, 2026, the company announced positive two-year data from the PRISM Phase 2b clinical trial evaluating 4D-150 in a broad wet AMD population. Results demonstrated a durable reduction in treatment burden and maintained visual acuity through two years with no new safety findings. Additionally, in late June 2026, the company completed patient enrollment for its global Phase 3 4FRONT-2 trial ahead of schedule.

What Firelda Watch includes for 4D Molecular Therapeutics, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of 4D Molecular Therapeutics, Inc. will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Hansa Biopharma AB (publ)
HNSA
HOLD
Bioarctic
BIOA B
BUY
Sprint Bioscience AB (publ)
SPRINT
NEUTRAL
Xbrane Biopharma AB (publ)
XBRANE
HOLD
SynAct Pharma AB
SYNACT
HOLD

Biotech

More companies in this sector

Want to follow 4D Molecular Therapeutics, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow 4D Molecular Therapeutics free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

4D Molecular Therapeutics, Inc. FDMT
4D Molecular Therapeutics — follow and we'll monitor it
Follow 4D Molecular Therapeutics free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.